R&D Tax Incentives

R&D Tax Incentives Hong Kong — Section 16B

Hong Kong's enhanced R&D deduction allows up to 300% deduction on qualifying R&D expenditure. Most companies significantly underutilise this — leaving hundreds of thousands on the table every year.

香港會計師公會註冊 24小時回覆 固定收費 100% 保密
免費諮詢
300% Enhanced deduction rate (first HKD 2M)
200% Rate on expenditure above HKD 2M
100% Basic deduction (all qualifying R&D)

R&D Tax Incentives

Hong Kong's enhanced R&D deduction allows up to 300% deduction on qualifying R&D expenditure. Most companies significantly underutilise this — leaving hundreds of thousands on the table every year.

⚠️

⚠ Most HK Companies Underclaim R&D Deductions

IRD's DIPN 49 defines qualifying R&D broadly — including software development, product improvement, and process R&D. Many companies expense R&D without claiming the enhanced deduction, missing the uplift that turns a 16.5% deduction into a 300% deduction on the first HKD 2 million.

常見困擾

您是否正面對以下稅務問題?

Identifying Qualifying Expenditure

Not all R&D spending qualifies for the enhanced rate. Wages, equipment, and contracted research at prescribed institutions qualify; market research and routine testing do not.

⚠ Risk: Overclaiming non-qualifying spend → IRD disallowance + penalties

Prescribed Research Institutions

The 300%/200% enhanced rate applies only to R&D outsourced to prescribed research institutions (universities, innovation centres). Internal R&D gets 100% only unless the enhanced conditions are met.

⚠ Risk: Missing prescribed institution qualification → claiming 100% instead of 300%

Documentation Requirements

IRD requires detailed records of R&D activities, project purpose, qualifying expenditure categorisation, and staff time allocation to support enhanced deduction claims.

⚠ Risk: Poor documentation → IRD rejects enhanced claim on audit

IP Ownership Requirement

For the enhanced rate, the R&D must be related to a trade or business carried on in HK, and any resulting IP should be owned or co-owned by the HK entity.

⚠ Risk: IP owned offshore → HK entity loses enhanced deduction entitlement
適合對象

適合對象

Technology and software companies

Companies developing proprietary software, apps, or platforms in HK.

Pharmaceutical and biotech firms

Life sciences companies conducting drug research, clinical trials, or formulation development.

Manufacturing companies with product R&D

Manufacturers improving products or production processes through systematic R&D.

Companies partnering with HK universities

Businesses with research collaborations with HKUST, HKU, CUHK, or PolyU.

服務範疇

服務範疇

R&D Expenditure Review

Analyse all R&D expenditure to identify qualifying amounts for the basic and enhanced deductions under s.16B IRO.

Per DIPN 49 guidance

Enhanced Deduction Claim

Prepare the R&D enhanced deduction claim for inclusion in the profits tax return, with full documentation package.

Project summaries + expenditure schedules

Prescribed Institution Structuring

Advise on how to structure R&D partnerships with HK prescribed research institutions to maximise the 300% rate.

University collaboration agreement review

R&D Tax Planning Strategy

Develop a multi-year R&D tax strategy — identifying optimal project structures, expenditure timing, and IP ownership arrangements.

Linked to patent box planning
服務流程

簡單、高效、專業

1

R&D Activity Mapping

Interview technical and finance teams to map all qualifying R&D activities and expenditure.

1-2 weeks
2

Qualifying Expenditure Analysis

Categorise expenditure by qualifying type and calculate basic vs enhanced claim.

1 week
3

Documentation Preparation

Prepare R&D project summaries and supporting documentation for IRD.

1-2 weeks
4

Annual Review

Annual review to capture new R&D activity and update the deduction claim.

Annual
準備好開始了嗎? 無需承諾,隨時取消
預約免費諮詢
客戶成功案例

為真實客戶帶來真實成果

Case Study

Fintech company — software R&D enhanced claim

HKD 660,000 節省
  • HKD 3.8M annual R&D expenditure identified
  • HKD 2M restructured to HKUST collaboration (300% rate)
  • Additional HKD 1.8M claimed at 200% rate
  • Total deduction: HKD 9.6M vs HKD 3.8M expensed
"We were expensing R&D but never claiming the enhanced deduction. That changes everything."
C
已驗證客戶 Case Study
Case Study

Medical device manufacturer — R&D + patent box combo

HKD 1,100,000 節省
  • R&D enhanced deduction HKD 580K annual saving
  • Patent box 5% rate on resulting royalty income
  • IP ownership confirmed in HK entity
  • DEMPE substance documented for BEPS compliance
"The combined R&D deduction and patent box saved us seven figures annually."
C
已驗證客戶 Case Study
★★★★★ 2,400+ 位客戶信賴我們的團隊
免費諮詢

免費專家諮詢

立即與資深稅務專家聯繫

  • 免費30分鐘初步諮詢
  • 資深註冊會計師為您服務
  • 無需承諾,隨時取消
HKICPA 註冊 24小時回覆 無需承諾
選擇我們的理由

為何選擇 TAX.hk

深厚的香港稅務專業知識

我們的註冊會計師擁有15年以上香港稅務經驗,時刻掌握稅務局的最新動態。

透明固定收費

無按小時計費的意外開支。開始前清楚了解費用。

24小時回覆

我們於一個工作天內回覆所有查詢,緊急情況4小時內處理。

嚴格保密

所有客戶資料均依據嚴格的專業保密責任妥善保管。

常見問題

常見問題

快速解答您的疑問

Qualifying R&D under s.16B(1) includes activities that are innovative, involve technical uncertainty, are systematic or investigative in nature, and aim to advance knowledge or create new/improved products, processes, or services. Routine product testing, market research, and quality control do NOT qualify.
The first HKD 2 million of qualifying R&D expenditure paid to a prescribed research institution attracts a 300% deduction — meaning a HKD 2M payment reduces assessable profits by HKD 6M. Expenditure above HKD 2M at a prescribed institution attracts 200%. In-house R&D qualifies for 100% (basic deduction only), plus potentially 200% if conditions met.
The list of prescribed research institutions includes the eight HK universities (HKU, CUHK, HKUST, PolyU, CityU, HKBU, HSUHK, EdUHK), various government-funded R&D centres, and other approved institutions listed in Schedule 45 of IRO. The list is updated periodically.
Only if the Mainland lab is a prescribed research institution under HK law — which most are not. For non-prescribed institution outsourcing, only the basic 100% deduction applies (if the expenditure otherwise qualifies). Subcontracting R&D to overseas non-prescribed labs does not attract enhanced rates.
Yes. Capital expenditure on R&D assets (equipment, machinery used for R&D) qualifies for capital allowances under s.16B(3), not the enhanced revenue deduction. Revenue expenditure (staff costs, consumables, payments to research institutions) qualifies for the enhanced deduction. The distinction requires careful analysis.
R&D deductions that cannot be utilised in the year because the company has insufficient profits can be carried forward indefinitely under s.19C IRO and offset against future profits. This makes early-stage R&D expenditure valuable even when the company is loss-making.

準備好開始了嗎?

立即預約資深香港稅務專家的免費諮詢。

本頁面僅提供一般資訊。如需針對您個人情況的建議,請諮詢合資格的香港稅務專業人士。